Vir Biotechnology, Inc. VIR Other Non-Current Liabilities
Other Non-Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Vir Biotechnology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherLiabilitiesNoncurrent.
The official record: Vir Biotechnology, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vir Biotechnology, Inc.'s other non-current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vir Biotechnology, Inc.'s other non-current liabilities?
- Vir Biotechnology, Inc. (VIR) reported other non-current liabilities of $19.42M in Q1 2026.
- How has Vir Biotechnology, Inc.'s other non-current liabilities changed year-over-year?
- Vir Biotechnology, Inc.'s other non-current liabilities increased by 31.1% year-over-year, from $14.81M to $19.42M.
- What is the long-term trend for Vir Biotechnology, Inc.'s other non-current liabilities?
- Over 5 years (2020 to 2025), Vir Biotechnology, Inc.'s other non-current liabilities has grown at a 41.2% compound annual growth rate (CAGR), from $3.85M to $21.58M.
- What does other non-current liabilities mean?
- Miscellaneous long-term obligations not classified in specific categories — pension liabilities, environmental remediation, and other long-term accruals.